🇺🇸 FDA
Patent

US 10160957

Development of dengue virus vaccine components

granted A61KA61K2039/5254A61P

Quick answer

US patent 10160957 (Development of dengue virus vaccine components) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 25 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 20 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K2039/5254, A61P, A61P31/12, A61P31/14